The Death Domain Kinase RIP Is Essential for TRAIL (Apo2L)-Induced Activation of IkB Kinase and c-Jun N-Terminal Kinase

Abstract

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) (Apo2 ligand [Apo2L]) is a member of the TNF superfamily and has been shown to have selective antitumor activity. Although it is known that TRAIL (Apo2L) induces apoptosis and activates NF-kB and Jun N-terminal kinase (JNK) through receptors such as TRAIL-R1 (DR4) and TRAIL-R2 (DR5), the components of its signaling cascade have not been well defined. In this report, we demonstrated that the death domain kinase RIP is essential for TRAIL-induced IkB kinase (IKK) and JNK activation. We found that ectopic expression of the dominant negative mutant RIP, RIP(559–671), blocks TRAIL-induced IKK and JNK activation. In the RIP null fibroblasts, TRAIL failed to activate IKK and only partially activated JNK. The endogenous RIP protein was detected by immunoprecipitation in the TRAIL-R1 complex after TRAIL treatment. More importantly, we found that RIP is not involved in TRAIL-induced apoptosis. In addition, we also demonstrated that the TNF receptor-associated factor 2 (TRAF2) plays little role in TRAIL-induced IKK activation although it is required for TRAIL-mediated JNK activation. These results indicated that the death domain kinase RIP, a key factor in TNF signaling, also plays a pivotal role in TRAIL-induced IKK and JNK activation.

7 Figures and Tables

Statistics

050100'03'05'07'09'11'13'15'17
Citations per Year

132 Citations

Semantic Scholar estimates that this publication has 132 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@inproceedings{Lin2000TheDD, title={The Death Domain Kinase RIP Is Essential for TRAIL (Apo2L)-Induced Activation of IkB Kinase and c-Jun N-Terminal Kinase}, author={Yong Lin and Anne Devin and Amy Cook and Maccon M . Keane and Michelle Kelliher and Stanley Lipkowitz and Zheng-gang Liu}, year={2000} }